|
WO2021078726A1
|
|
Pharmaceutical compositions of gd-based contrast agents
|
|
WO2021052982A1
|
|
Ca-ix aptamers and diagnostic and therapeutic uses thereof
|
|
WO2020229438A1
|
|
Modified cyanine dyes and conjugates thereof
|
|
WO2020127154A1
|
|
Pharmaceutical compositions comprising gd-complexes and polyarylene additives
|
|
WO2020099398A1
|
|
Chelating aazta conjugates and complexes thereof
|
|
WO2020099277A1
|
|
Gene signatures for the prediction of prostate cancer recurrence
|
|
CA3105610A1
|
|
Gadolinium bearing pcta-based contrast agents
|
|
WO2020020947A1
|
|
Icam-1 aptamers, diagnostic and therapeutic uses thereof
|
|
CN111356691A
|
|
Solid phase synthesis of NIR fluorescent probes
|
|
US2020131036A1
|
|
Process for the recovery of iodine from aqueous solutions
|
|
WO2018189136A1
|
|
Improved synthesis of nir fluorescent probe
|
|
CN109963792A
|
|
Pass through the container-closure of rotation process
|
|
KR20190102175A
|
|
Container stopper operated by connecting device
|
|
CN110072560A
|
|
For the method using compound label sensitivity and thermal sensitivity targeting biological molecules based on technetium
|
|
CN109963838A
|
|
Dimerization contrast agent
|
|
CN110023279A
|
|
The Mechano-chemical Synthesizing of radiography agent intermediate
|
|
CN108779082A
|
|
contrast agent
|
|
CN108369266A
|
|
The pulse CEST imagings of ratio metering
|
|
EP3386953A1
|
|
Contrast agents
|
|
MX2018007043A
|
|
Dimeric contrast agents.
|
